News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
215 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38488)
2025 (26387)
Month
January (2488)
February (2603)
March (3228)
April (2950)
May (3962)
June (3500)
July (2854)
August (3142)
September (3205)
October (3540)
November (3386)
December (2332)
Day
1 (247)
2 (234)
3 (123)
4 (6)
5 (2)
6 (157)
7 (294)
8 (215)
9 (227)
10 (147)
11 (6)
12 (2)
13 (213)
14 (201)
15 (161)
16 (149)
17 (68)
19 (2)
20 (132)
21 (113)
22 (70)
23 (4)
24 (6)
26 (9)
27 (154)
28 (186)
29 (127)
30 (131)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
19
20
21
22
23
24
26
27
28
29
30
Business
Genomic Health Announces Third Quarter 2017 Financial Results and Reports Recent Business Progress
Total revenue was $83.8 million in the third quarter of 2017, compared with $82.3 million in the third quarter of 2016.
November 8, 2017
·
24 min read
Business
Aerie Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Business Update
As of September 30, 2017, Aerie had cash, cash equivalents and investments of $282.2 million.
November 8, 2017
·
14 min read
Business
Nortech Systems Reports Third Quarter Results
Nortech Systems today reported net sales of $28.3 million for the third quarter ended September 30, compared with net sales of $29.7 million for the third quarter of 2016.
November 8, 2017
·
5 min read
Business
Profound Medical Corp. Announces Third Quarter 2017 Financial Results
For the quarter ended September 30, 2017, the Company recorded revenues of $1,465,412, with $1,452,773 from the sale of products and $12,639 from installation and training services.
November 8, 2017
·
12 min read
Business
Alder BioPharmaceuticals Announces Third Quarter 2017 Financial and Operating Results
Research and development expenses for the quarter ended September 30, 2017 totaled $52.2 million, compared to $29.5 million for the same period in 2016.
November 8, 2017
·
9 min read
Business
REVA Medical Reports Third Quarter 2017 Financial Results
The Company initiated commercial sales of the Fantom bioresorbable scaffold and reported total billings for shipped product of $105,000 with $17,000 of revenue recognized for the third quarter of 2017 compared to no billings or revenue for the same period in 2016.
November 8, 2017
·
10 min read
Bio NC
RedHill Biopharma Announces Proposed Public Offering of Its American Depositary Shares
The Company intends to use the proceeds from the offering to fund clinical development programs, for potential acquisitions, to support commercial operations and for general corporate purposes.
November 8, 2017
·
7 min read
Business
TESARO Announces Third-Quarter 2017 Operating Results
TESARO reported total revenue of $142.8 million for the third quarter of 2017, compared to $17.0 million for the third quarter of 2016.
November 8, 2017
·
16 min read
Business
ChemoCentryx Reports Third Quarter 2017 Financial Results and Recent Highlights
Pro forma cash, cash equivalents, investments and remaining upfront commitments totaled $154.8 million at September 30, 2017.
November 8, 2017
·
9 min read
Business
Amedisys Reports Third Quarter 2017 Financial Results
Net service revenue increased $18.6 million to $380.2 million compared to $361.6 million in 2016.
November 8, 2017
·
23 min read
Previous
11 of 22
Next